news
09-07-2012, 09:30 PM
Mylan, the maker of the epinephrine injector EpiPen, is expanding its marketing efforts in the face of new, competing devices and the surging rates of allergies in children.http://rss.nytimes.com/c/34625/f/642562/s/2331d45e/mf.gif
More... (http://www.nytimes.com/2012/09/08/business/mylan-invests-in-epipen-as-child-allergies-increase.html?partner=rss&emc=rss)
More... (http://www.nytimes.com/2012/09/08/business/mylan-invests-in-epipen-as-child-allergies-increase.html?partner=rss&emc=rss)